Primary end points studied were efficacy ( maximum flow rate -LSB- Qmax -RSB- , International Prostate Symptom Score ) and safety ( adverse events , decline in postoperative serum sodium -LSB- Na + -RSB- and haemoglobin -LSB- Hb -RSB- levels ) .